← All Startups
Obsidian Therapeutics Series C
Cell and gene therapies
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Location
Cambridge, MA
Stage
Series C
Website
obsidiantx.com
LinkedIn
View profile
BiotechnologyHealth CarePharmaceutical
Founders
V
Vic Myer ’89
LinkedIn
J
Jeffrey Trigilio ’06
LinkedIn
Similar Startups
Centivax
Broad-spectrum vaccine
Stephanie Wisner ’16, ,
Patientory
Web3 for health data
Chrissa McFarlane ’11, ,
Latent Series A
Medical language models for healthcare overhead
Rishabh Jain ’17, ,
SimpliFed Series A
Baby breastfeeding virtual care
Andrea Ippolito ’06, MEng ’07, ,
ModMed
Software for specialty medical practices
Daniel Cane ’98, ,
Ceribell Series C
Point-of-care EEG for seizure triage and treatment optimization
Xingjuan Chao, PhD ’05, ,